Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,554 | 172,560 | 158,709 | 141,490 | 144,200 |
| Marketable Securities | 400,523 | 351,721 | 381,211 | 434,458 | 462,167 |
| Receivables | 1,399 | 3,255 | 2,628 | 3,040 | 5,767 |
| TOTAL | $511,650 | $542,751 | $556,459 | $590,887 | $620,326 |
| Non-Current Assets | |||||
| PPE Net | 18,457 | 18,644 | 19,625 | 20,195 | 21,024 |
| Other Non-Current Assets | 84,056 | 85,997 | 87,822 | 89,828 | 91,007 |
| TOTAL | $102,513 | $104,641 | $107,447 | $110,023 | $112,031 |
| Total Assets | $614,163 | $647,392 | $663,906 | $700,910 | $732,357 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,352 | 4,520 | 4,637 | 6,833 | 3,049 |
| Accrued Expenses | 17,053 | 24,342 | 21,918 | 19,762 | 16,552 |
| TOTAL | $51,981 | $42,909 | $42,642 | $40,367 | $31,294 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 19,060 | 3,605 | 5,719 | 3,479 | 1,473 |
| Other Non-Current Liabilities | 59,149 | 60,818 | 61,982 | 63,296 | 66,261 |
| TOTAL | $88,669 | $111,083 | $112,713 | $114,449 | $117,994 |
| Total Liabilities | $140,650 | $153,992 | $155,355 | $154,816 | $149,288 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,143 | 88,796 | 84,664 | 84,625 | 83,966 |
| Common Shares | 89 | 89 | 85 | 85 | 84 |
| Retained earnings | -774,047 | -743,014 | -692,979 | -642,846 | -593,041 |
| Other shareholders' equity | 393 | 428 | 1,143 | -615 | -500 |
| TOTAL | $473,513 | $493,400 | $508,551 | $546,094 | $583,069 |
| Total Liabilities And Equity | $614,163 | $647,392 | $663,906 | $700,910 | $732,357 |